Loading organizations...
Time Prediction, Inc. develops advanced diagnostic and predictive strategies for intractable neurological diseases, leveraging proprietary digital iPSC technology. The company focuses on exploratory research and clinical development of diagnostic drugs, quasi-drugs, and medical devices. Utilizing patient-derived iPS cells and sophisticated digital analysis, they unravel disease mechanisms and forecast progression.
Established on August 20, 2021, the company arose from the foundational research of Haruhisa Inoue, a Professor at Kyoto University's iPS Cell Research Institute. Professor Inoue's pioneering digital technology for disease prediction, utilizing patient-specific iPS cells, formed its core intellectual property. Naka Hidaka is the Representative Director and President.
Time Prediction, Inc. aims to serve medical and pharmaceutical sectors by providing tools for early diagnosis and prognosis prediction, primarily for neurological disorders. The company's vision is to contribute to a disease-free society through advancing its digital iPS cell technology, enabling personalized and proactive healthcare.
Time Prediction has raised $940K across 2 funding rounds.
Time Prediction has raised $940K in total across 2 funding rounds.
Time Prediction appears to refer to two distinct entities in public sources: (A) TimeGPT / Nixtla — a time‑series AI product and company working on foundation models for forecasting, and (B) Time Prediction, Inc. — a small biotech / digital iPSC spin‑out from Kyoto University that describes itself as providing predictive strategies for intractable diseases[3][6]. I’ll prepare the requested profile for the most likely interpretation based on your note “Time Prediction is a technology company.” If you meant the Kyoto University spin‑out, say so and I will switch focus; below I profile the time‑series AI company (TimeGPT / Nixtla ecosystem), which is the best documented technology company near the name “Time Prediction.”
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
If you intended the Kyoto University spin‑out “Time Prediction, Inc.” (a biotech iPSC predictive‑medicine company), I can produce the same structured profile focused on that firm — say “biotech” and I’ll switch.
Time Prediction has raised $940K across 2 funding rounds. Most recently, it raised $400K Series U in December 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 1, 2024 | $400K Series U | — | KK Fund | Announced |
| Jan 1, 2023 | $540K Seed | — | KK Fund | Announced |
Time Prediction has raised $940K in total across 2 funding rounds.
Time Prediction's investors include KK Fund.